(Q35299762)

7 August 2017

1 reference

title

Dye-induced nephropathy (English)

1 reference

7 August 2017

Samuel N Heyman

1

1 reference

7 August 2017

Seymour Rosen

series ordinal

2

1 reference

7 August 2017

publication date

1 September 2003

1 reference

7 August 2017

published in

Seminars in Nephrology

1 reference

7 August 2017

volume

23

1 reference

7 August 2017

issue

5

1 reference

7 August 2017

page(s)

477-485

1 reference

Effects of furosemide on medullary oxygenation in younger and older subjects

7 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Pathophysiology of radiocontrast nephropathy: a role for medullary hypoxia

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Kidney Injury Molecule-1 (KIM-1): a novel biomarker for human renal proximal tubule injury

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Animal models of acute tubular necrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Hypercholesterolemia aggravates radiocontrast nephrotoxicity: protective role of L-arginine

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Risk of radiocontrast nephropathy in patients with and without diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Effects of dopamine and aminophylline on contrast-induced acute renal failure after coronary angioplasty in patients with preexisting renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Fenoldopam mesylate blocks reductions in renal plasma flow after radiocontrast dye infusion: a pilot trial in the prevention of contrast nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Prospective randomized study of N-acetylcysteine, fenoldopam, and saline for prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

The role of theophylline in contrast-induced nephropathy: a case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Effect of theophylline on contrast material-nephropathy in patients with chronic renal insufficiency: controlled, randomized, double-blinded study.

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Prospective study of atrial natriuretic peptide for the prevention of radiocontrast-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Exacerbation of radiocontrast nephrotoxicity by endothelin receptor antagonism

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Prostaglandin E1: a new agent for the prevention of renal dysfunction in high risk patients caused by radiocontrast media? PGE1 Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial).

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Acetylcysteine and contrast agent-associated nephrotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

Acetylcysteine and nephrotoxic effects of radiographic contrast agents--a new use for an old drug

1 reference

https://api.crossref.org/works/10.1016%2FS0270-9295%2803%2900092-5

7 January 2021

10.1016/S0270-9295(03)00092-5

Identifiers

DOI

1 reference

7 August 2017

1 reference